fda approval status of bpc-157 tb-500 cjc-1295 ipamorelin FDA's Overreach on Compounded Peptides Peptides are having a moment.
Description
In this situation you can think of them as soldiers that help ward off the bad guys
This vitamin is key in breaking down homocysteine
Marketing pages also highlight reviews and program claims
The FDAs current safety page continues to cite concerns about immunogenicity, peptide impurities and limited safety data, and the agency has stated that a substance may still pose significant safety risks
